These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 861060)

  • 1. Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
    Subbarao K; Rucinski B; Niewiarowski S
    Biochem Pharmacol; 1977 May; 26(9):906-7. PubMed ID: 861060
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Binding of (14C) dipyradamole (RA 8) to platelets and inhibition of ADP induced platelet aggregation.
    Subbarao K; Rucinski B; Niewarowski S
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552-3. PubMed ID: 1198424
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.
    Subbarao K; Rucinski B; Rausch MA; Schmid K; Niewiarowski S
    J Clin Invest; 1977 Oct; 60(4):936-43. PubMed ID: 893681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory mechanism of dipyridamole on platelet aggregation ex vivo.
    Fukawa K; Saitoh K; Irino O; Ohkubo K; Hashimoto S
    Thromb Res; 1982 Aug; 27(3):333-40. PubMed ID: 6291192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
    Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dipyridamole-like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets.
    Söderbäck U; Sollevi A
    Thromb Res; 1991 Nov; 64(3):355-62. PubMed ID: 1666697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine-3',5'-diphosphate and coenzyme A--effects on platelet function.
    Subbarao K; Kuchibhotla J
    Biochem Pharmacol; 1978; 27(8):1193-6. PubMed ID: 697919
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosine metabolism in platelets and plasma.
    Caen JP; Jenkins CS; Michel H; Chivot JJ; Levy-Toledano S; Rendu F
    Ser Haematol; 1973; 6(3):317-32. PubMed ID: 4777837
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dipyridamol on the electrokinetic potential of platelets.
    Aznar J; Vallés J
    Rev Esp Fisiol; 1974 Jun; 30(2):77-9. PubMed ID: 4278529
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD; Agarwal KC; Parks RE
    Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole.
    Edlund A; Sidén A; Sollevi A
    Thromb Res; 1987 Jan; 45(2):183-90. PubMed ID: 3563983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
    Lakin KM; Makarow WA; Mular AG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
    Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships.
    Beretz A; Cazenave JP; Anton R
    Agents Actions; 1982 Jul; 12(3):382-7. PubMed ID: 6182778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thio reagents on platelet transport processes and responses to stimuli.
    MacIntyre DE; Grainge CA; Drummond AH; Gordon JL
    Biochem Pharmacol; 1977 Feb; 26(4):319-23. PubMed ID: 849322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.